Bococizumab is a cutting-edge anti-PCSK9 antibody specifically developed to address hypercholesterolemia. It therapeutic agent interacts with the PCSK9 protein, a key regulator of cholesterol amounts. By inhibiting the https://zaynpgth940788.wikiannouncement.com/10166988/bococizumab_a_novel_anti_pcsk9_antibody_for_hypercholesterolemia